Potential Thai medicinal plants for neurodegenerative diseases: A review focusing on the anti-glutamate toxicity effect.
Alzheimer’s disease
Glutamate
Herbal medicine
Neuroprotective
Neurotoxicity
Oxidative stress
Plant extract
Traditional medicine
Journal
Journal of traditional and complementary medicine
ISSN: 2225-4110
Titre abrégé: J Tradit Complement Med
Pays: Netherlands
ID NLM: 101605474
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
received:
28
12
2019
revised:
12
03
2020
accepted:
18
03
2020
entrez:
17
7
2020
pubmed:
17
7
2020
medline:
17
7
2020
Statut:
epublish
Résumé
Neurodegenerative diseases (NDD) are a range of debilitating conditions of the brain involving progressive loss of neurons, many of which are still currently incurable despite enormous efforts on drug discovery and development in the past decade. As NDD is closely linked to old age, the rapid worldwide growth in the aging population contributes to an increasing number of people with one of these incurable diseases and therefore it is considered a significant global health issue. There is an urgent need for novel effective treatments for NDD, and many new research strategies are centered on traditional medicine as an alternative or complementary solution. Several previous findings have suggested that glutamate toxicity drives neurodegeneration in many NDD, and the medicinal plants with anti-glutamate toxicity properties can be potentially used for their treatment. In order to obtain data relating to natural products against glutamate toxicity, six candidate plant species of Thailand were identified. Studies utilizing these herbs were searched for using the herb name (Latin and common names) along with the term "glutamate" in the following databases across all available years: PubMed, Scopus, and Google Scholar. This review emphasizes the importance of glutamate toxicity in NDD and summarizes individual plants and their active constituents with the mechanism of action against glutamate toxicity-mediated neuronal cell death that could be a promising resource for future NDD therapy. Alzheimer's disease, Neurodegenerative diseases, Cell culture, Molecular Biology, Traditional herbal medicine, Oxidative stress, Glutamate neurotransmitter.
Identifiants
pubmed: 32670825
doi: 10.1016/j.jtcme.2020.03.003
pii: S2225-4110(19)31301-X
pmc: PMC7340876
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
301-308Informations de copyright
© 2020 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier Taiwan LLC.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
J Psychiatry Neurosci. 2013 Jan;38(1):6-23
pubmed: 22894822
J Neurodegener Dis. 2013;2013:563481
pubmed: 26316993
Oxid Med Cell Longev. 2019 Nov 29;2019:7024785
pubmed: 31871554
Phytother Res. 2016 Jun;30(6):929-39
pubmed: 26915634
Pharmacol Biochem Behav. 2012 Feb;100(4):656-64
pubmed: 21889952
Phytochemistry. 2001 Nov;58(5):811-7
pubmed: 11672747
Lancet Neurol. 2016 Sep;15(10):1089-102
pubmed: 27571160
Front Med. 2012 Mar;6(1):8-21
pubmed: 22460444
Science. 2012 Jun 29;336(6089):1658-61
pubmed: 22745417
Nat Rev Neurosci. 2002 Sep;3(9):748-55
pubmed: 12209123
Pharm Biol. 2015 Jun;53(6):862-9
pubmed: 25431131
Eur J Pharmacol. 2009 Sep 1;617(1-3):1-11
pubmed: 19580806
Apoptosis. 2010 Nov;15(11):1382-402
pubmed: 20213199
Biotechnol Adv. 2014 Nov 1;32(6):1065-76
pubmed: 25048704
BMC Complement Altern Med. 2017 Dec 28;17(1):551
pubmed: 29282044
Antioxid Redox Signal. 2009 Jul;11(7):1587-602
pubmed: 19413484
Acta Pharmacol Sin. 2009 Apr;30(4):379-87
pubmed: 19343058
Neurochem Int. 2007 Nov-Dec;51(6-7):333-55
pubmed: 17517448
CNS Drugs. 2003;17(9):641-52
pubmed: 12828500
Evid Based Complement Alternat Med. 2015;2015:970354
pubmed: 26798403
Horm Behav. 2014 Sep;66(4):602-18
pubmed: 25205317
Neurochem Res. 2013 Oct;38(10):2201-15
pubmed: 23949198
Annu Rev Pharmacol Toxicol. 2010;50:295-322
pubmed: 20055706
Expert Opin Investig Drugs. 2017 Jun;26(6):735-739
pubmed: 28460541
J Med Assoc Thai. 2008 Feb;91(2):208-14
pubmed: 18389986
Asian Pac J Cancer Prev. 2014;15(6):2825-30
pubmed: 24761908
Life Sci. 2006 Jul 10;79(7):709-16
pubmed: 16566948
Naunyn Schmiedebergs Arch Pharmacol. 2010 Jan;381(1):93-105
pubmed: 19904526
Int J Mol Sci. 2012;13(4):5074-97
pubmed: 22606031
Curr Top Med Chem. 2001 Dec;1(6):497-506
pubmed: 11895126
J Ethnopharmacol. 2014;151(1):528-35
pubmed: 24252493
J Ethnopharmacol. 2008 Oct 30;120(1):112-7
pubmed: 18755259
J Alzheimers Dis. 2006 Aug;9(3):243-51
pubmed: 16914834
Brain Sci. 2018 Sep 15;8(9):
pubmed: 30223579
Cell Biochem Funct. 2003 Mar;21(1):1-9
pubmed: 12579515
Phytother Res. 2012 Aug;26(8):1205-10
pubmed: 22228592
Int J Mol Sci. 2017 Apr 24;18(4):
pubmed: 28441758
Rapid Commun Mass Spectrom. 2014 Nov 15;28(21):2363-70
pubmed: 25279750
J Nat Med. 2011 Jan;65(1):1-8
pubmed: 20658198
Maturitas. 2014 Mar;77(3):209-20
pubmed: 24486046
Food Chem Toxicol. 2017 May;103:279-288
pubmed: 28315776
J Neural Transm (Vienna). 2014 Aug;121(8):799-817
pubmed: 24578174
BMC Complement Altern Med. 2018 Oct 16;18(1):278
pubmed: 30326896
Oxid Med Cell Longev. 2017;2017:5414297
pubmed: 29181126
Chem Biol Interact. 2012 Aug 30;199(2):87-95
pubmed: 22735309
Evid Based Complement Alternat Med. 2006 Jun;3(2):217-22
pubmed: 16786051
Front Neurosci. 2015 Dec 16;9:469
pubmed: 26733784
J Nutr. 2000 Apr;130(4S Suppl):1007S-15S
pubmed: 10736372
Interdiscip Toxicol. 2012 Dec;5(4):201-6
pubmed: 23554564
Phytomedicine. 2014 Sep 25;21(11):1249-55
pubmed: 25172786
Pharmaceuticals (Basel). 2018 May 11;11(2):
pubmed: 29751602
Molecules. 2011 Jul 26;16(8):6322-38
pubmed: 21792150
Brain Res. 2017 Feb 15;1657:87-94
pubmed: 27923632
Phytother Res. 2015 Aug;29(8):1131-6
pubmed: 25900014
Food Nutr Res. 2017 Aug 13;61(1):1361779
pubmed: 28970777
BMC Complement Altern Med. 2018 Jul 24;18(1):223
pubmed: 30041641
Front Cell Neurosci. 2015 Mar 17;9:91
pubmed: 25852482